PersistenceMarketResearch states that the global Shrimp Disease Diagnostics market will witness a CAGR of more than 6% between 2020 and 2030.
Shrimp farming is witnessing an increasing demand since the last few years. This certainly calls for availability of molecular diagnostics tools to detect the diseases in shrimps. The diagnostic methods are inclusive of histopathology, wet mount preparations, conventional microbiology, electron microscopy, bioassay methods, and serological techniques. The techniques could be confirmative and presumptive.
Though tissue culture is looked upon as one of the standard tools in veterinary and medical diagnostics labs, it has not seen the light of the day as a routine, useable diagnostic tool related to shrimp pathogens.
Get Full Article Here: https://www.persistencemarketresearch.com/samples/29626
These days, shrimp disease diagnostic laboratories use real-time PCR and nested PCR/RT-PCR for confirmatory diagnosis. The shrimp disease diagnostics market also witnesses the usage with the objective of raising farm-level aquatic animal health management.
By type of disease, the shrimp disease diagnostics span EMS (Early Mortality Syndrome), YHV/GAV (Yellow Head/Gill Associated Virus), TSV (Taura Syndrome Virus), WSSV (White Spot Syndrome Virus), and others. By kits, it says rapid testing kits and assay based kits. The end-users include aquaculture and marine laboratories, fisheries, and education and research institutes.
Another trend catching up is that of commercialization and intensification of aquaculture, thereby bolstering shrimp disease diagnostics market.
By geography, out of North America, Europe, LATAM, the Asia-Pacific, and MEA, the Asia-Pacific holds the largest market share due to shrimp farming flourishing throughout. The status quo is expected to remain unchanged even in the upcoming period. North America and Europe have already been the flag bearers regarding imports. LATAM is expected to create greater strides going forward with people venturing into shrimp farming.
The key market participants include Speedy Assay Sdn Bhd, HiMedia Laboratories, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, SUREBIO, and Auro Biotechnologies.
